TY - JOUR
T1 - Effectiveness of 80% vs 30–35% fraction of inspired oxygen in patients undergoing surgery
T2 - an updated systematic review and meta-analysis
AU - de Jonge, Stijn
AU - Egger, Matthias
AU - Latif, Asad
AU - Loke, Yoon Kong
AU - Berenholtz, Sean
AU - Boermeester, Marja
AU - Allegranzi, Benedetta
AU - Solomkin, Joseph
N1 - Publisher Copyright:
© 2018 World Health Organization
PY - 2019/3
Y1 - 2019/3
N2 - Background: In 2016, the World Health Organization (WHO) strongly recommended the use of a high fraction of inspired oxygen (FiO 2 ) in adult patients undergoing general anaesthesia to reduce the risk of surgical site infection (SSI). Since then, further trials have been published, trials included previously have come under scrutiny, and one article was retracted. We updated the systematic review on which the recommendation was based. Methods: We performed a systematic literature search from January 1990 to April 2018 for RCTs comparing the effect of high (80%) vs standard (30–35%) FiO 2 on the incidence of SSI. Studies retracted or under investigation were excluded. A random effects model was used for meta-analyses; the sources of heterogeneity were explored using meta-regression. Results: Of 21 RCTs included, six were newly identified since the publication of the WHO guideline review; 17 could be included in the final analyses. Overall, no evidence for a reduction of SSI after the use of high FiO 2 was found [relative risk (RR): 0.89; 95% confidence interval (CI): 0.73–1.07]. There was evidence that high FiO 2 was beneficial in intubated patients [RR: 0.80 (95% CI: 0.64–0.99)], but not in non-intubated patients [RR: 1.20 (95% CI: 0.91–1.58); test of interaction; P=0.048]. Conclusions: The WHO updated analyses did not show definite beneficial effect of the use of high perioperative FiO 2 , overall, but there was evidence of effect of reducing the SSI risk in surgical patients under general anaesthesia with tracheal intubation. However, the evidence for this beneficial effect has become weaker and the strength of the recommendation needs to be reconsidered.
AB - Background: In 2016, the World Health Organization (WHO) strongly recommended the use of a high fraction of inspired oxygen (FiO 2 ) in adult patients undergoing general anaesthesia to reduce the risk of surgical site infection (SSI). Since then, further trials have been published, trials included previously have come under scrutiny, and one article was retracted. We updated the systematic review on which the recommendation was based. Methods: We performed a systematic literature search from January 1990 to April 2018 for RCTs comparing the effect of high (80%) vs standard (30–35%) FiO 2 on the incidence of SSI. Studies retracted or under investigation were excluded. A random effects model was used for meta-analyses; the sources of heterogeneity were explored using meta-regression. Results: Of 21 RCTs included, six were newly identified since the publication of the WHO guideline review; 17 could be included in the final analyses. Overall, no evidence for a reduction of SSI after the use of high FiO 2 was found [relative risk (RR): 0.89; 95% confidence interval (CI): 0.73–1.07]. There was evidence that high FiO 2 was beneficial in intubated patients [RR: 0.80 (95% CI: 0.64–0.99)], but not in non-intubated patients [RR: 1.20 (95% CI: 0.91–1.58); test of interaction; P=0.048]. Conclusions: The WHO updated analyses did not show definite beneficial effect of the use of high perioperative FiO 2 , overall, but there was evidence of effect of reducing the SSI risk in surgical patients under general anaesthesia with tracheal intubation. However, the evidence for this beneficial effect has become weaker and the strength of the recommendation needs to be reconsidered.
KW - general anaesthesia
KW - hyperoxia
KW - postoperative outcome
KW - surgical site infection
KW - surgical wound infection
UR - http://www.scopus.com/inward/record.url?scp=85059470662&partnerID=8YFLogxK
U2 - 10.1016/j.bja.2018.11.024
DO - 10.1016/j.bja.2018.11.024
M3 - Review article
C2 - 30770050
AN - SCOPUS:85059470662
SN - 0007-0912
VL - 122
SP - 325
EP - 334
JO - British Journal of Anaesthesia
JF - British Journal of Anaesthesia
IS - 3
ER -